Rx Discounts Do Not Require Restrictive Formularies, PhRMA Tells USP
Executive Summary
Medicare prescription drug plan sponsors will be able to negotiate significant discounts even under a model drug classification system that includes a large number of categories and classes, the Pharmaceutical Research & Manufacturers of America said
You may also be interested in...
PBMs’ Medicare Formulary Lobbying Takes On New Dimensions
The Pharmaceutical Care Management Association's efforts to ensure the Medicare model formulary guidelines will enable pharmacy benefit managers to negotiate deep discounts on drugs have expanded to include print advertising and direct appeals to the Centers for Medicare & Medicaid Services
PBMs’ Medicare Formulary Lobbying Takes On New Dimensions
The Pharmaceutical Care Management Association's efforts to ensure the Medicare model formulary guidelines will enable pharmacy benefit managers to negotiate deep discounts on drugs have expanded to include print advertising and direct appeals to the Centers for Medicare & Medicaid Services
USP Formulary Guide Needs Overhaul To Meet Access Goal, PhRMA, BIO Say
The U.S. Pharmacopeia should completely overhaul its draft model formulary guidelines for Medicare Part D in order to fulfill its task of creating guidelines that prevent health plans from discriminating against certain Medicare beneficiaries, PhRMA and BIO said